Abstract

Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs) are considered important for the entry of many different viruses. Previously, we demonstrated that heparanase (HPSE), the host enzyme responsible for cleaving HS chains, is upregulated by herpes simplex virus-1 (HSV-1) infection. Higher levels of HPSE accelerate HS removal from the cell surface, facilitating viral release from infected cells. Here, we study the effects of overexpressing HPSE on viral entry, cell-to-cell fusion, plaque formation, and viral egress. We provide new information that higher levels of HPSE reduce syncytial plaque formation while promoting egress and extracellular release of the virions. We also found that transiently enhanced expression of HPSE did not affect HSV-1 entry into host cells or HSV-1-induced cell-to-cell fusion, suggesting that HPSE activation is tightly regulated and facilitates extracellular release of the maturing virions. We demonstrate that an HSPG-shedding agonist, PMA; a protease, thrombin; and a growth factor, EGF as well as bacterially produced recombinant heparinases resulted in enhanced HSV-1 release from HeLa and human corneal epithelial (HCE) cells. Our findings here underscore the significance of syndecan-1 functions in the HSV-1 lifecycle, provide evidence that the shedding of syndecan-1 ectodomain is another way HPSE works to facilitate HSV-1 release, and add new evidence on the significance of various HSPG shedding agonists in HSV-1 release from infected cells.

Highlights

  • Herpes simplex virus type-1(HSV-1) is a member of the alpha herpesvirus subfamily of herpesviruses

  • Does HPSE have the function of degrading Heparan sulfate (HS) chains, and it enhances the shedding of heparan sulfate proteoglycans (HSPGs) especially syndecan1 from the cell surface

  • This study highlights the role of HPSE in herpes simplex virus-1 (HSV-1) release from infected cells by syndecan-1 shedding

Read more

Summary

Introduction

Herpes simplex virus type-1(HSV-1) is a member of the alpha herpesvirus subfamily of herpesviruses It is a neurotropic virus capable of infecting the nervous system and causing neurological diseases. Fever blisters are the most common attributes of an HSV-1 disease It is a leading cause of infectious corneal blindness in the developed countries, and sporadic, fatal encephalitis worldwide [2,3]. As a proteoglycan responsible for much of the presence of HS near the cell surface, syndecan expression has an inherent potential to prevent viral egress by trapping the exiting virions. Agents that serve to accelerate the syndecan-1 shedding process would lead to an increase in viral egress. Treating HSV-1 infected cells with the syndecan shedding agonists results in an enhanced virus release from infected cells. We show that shedding agonists indiscriminately facilitate HSV-1 release from infected cells

Cell Culture and Viruses
HSV-1 Entry Assay
Cell-to-Cell Fusion Assay
Immunoblotting
Cytotoxicity Assays
Plaque Assays
HSV-1 Egress Assay after HPSE Overexpression
HSV-1 Release after Heparinase Treatment
2.11. Immunofluorescence Microscopy
2.12. Flow Cytometry
2.13. Slot Blot Assay
2.14. MTT Assay
2.15. Statistical Analyis
Results
Transient
Recombinant Heparinase
Recombinant
The Results are mean oftime
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call